Galectin-3 Promotes Vascular Remodeling and Contributes to Pulmonary Hypertension

被引：27

作者：

Barman, Scott A. ^{[1
]}

Chen, Feng ^{[1
,2
]}

Li, Xueyi ^{[1
]}

Haigh, Stephen ^{[1
]}

Stepp, David W. ^{[1
]}

Kondrikov, Dmitry ^{[1
]}

Mahboubi, Keyvan ^{[1
]}

Bordan, Zsuzsanna ^{[1
]}

Traber, Peter ^{[3
]}

Su, Yunchao ^{[1
]}

Fulton, David J. R. ^{[1
]}

机构：

[1] Augusta Univ, Augusta, GA 30904 USA

[2] Nanjing Med Univ, Nanjing, Jiangsu, Peoples R China

[3] Galectin Therapeut Inc, Norcross, GA USA

来源：

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2018年 / 197卷 / 11期

关键词：

ARTERIAL-HYPERTENSION;

D O I：

10.1164/rccm.201711-2308LE

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

页码：1488 / 1492

页数：6

共 10 条

[1] NADPH Oxidase 4 Is Expressed in Pulmonary Artery Adventitia and Contributes to Hypertensive Vascular Remodeling [J].

Barman, Scott A. ;

Chen, Feng ;

Su, Yunchao ;

Dimitropoulou, Christiana ;

Wang, Yusi ;

Catravas, John D. ;

Han, Weihong ;

Orfi, Laszlo ;

Szantai-Kis, Csaba ;

Keri, Gyorgy ;

Szabadkai, Istvan ;

Barabutis, Nektarios ;

Rafikova, Olga ;

Rafikov, Ruslan ;

Black, Stephen M. ;

Jonigk, Danny ;

Giannis, Athanassios ;

Asmis, Reto ;

Stepp, David W. ;

Ramesh, Ganesan ;

Fulton, David J. R. .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2014, 34 (08) :1704-+

[2] Galectin-3 levels are associated with right ventricular functional and morphologic changes in pulmonary arterial hypertension [J].

Fenster, Brett E. ;

Lasalvia, Luis ;

Schroeder, Joyce D. ;

Smyser, Jamey ;

Silveira, Lori J. ;

Buckner, J. Kern ;

Brown, Kevin K. .

HEART AND VESSELS, 2016, 31 (06) :939-946

[3] Usefulness of A Mouse Model of Reversible Pulmonary Arterial Hypertension: Be Cautious, Choose Carefully [J].

Gomez-Arroyo, Jose ;

Voelkel, Norbert F. ;

Bogaard, Harm J. ;

Taraseviciene-Stewart, Laima .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2012, 185 (12) :1326-1326

[4]

Guo SM, 2015, INT J CLIN EXP MED, V8, P15302

[5] Galectin-3 inhibition ameliorates hypoxia-induced pulmonary artery hypertension [J].

Hao, Mingwen ;

Li, Miaomiao ;

Li, Wenjun .

MOLECULAR MEDICINE REPORTS, 2017, 15 (01) :160-168

[6] Randomised clinical study: GR-MD-02, a galectin-3 inhibitor, vs. placebo in patients having non-alcoholic steatohepatitis with advanced fibrosis [J].

Harrison, S. A. ;

Marri, S. R. ;

Chalasani, N. ;

Kohli, R. ;

Aronstein, W. ;

Thompson, G. A. ;

Irish, W. ;

Miles, M. V. ;

Xanthakos, S. A. ;

Lawitz, E. ;

Noureddin, M. ;

Schiano, T. D. ;

Siddiqui, M. ;

Sanyal, A. ;

Neuschwander-Tetri, B. A. ;

Traber, P. G. .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 44 (11-12) :1183-1198

[7] Galectin-3: The Bridge over Troubled Waters [J].

Koenigshoff, Melanie ;

Rojas, Mauricio .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2012, 185 (05) :473-475

[8] Galectin-3 Levels Are Elevated and Predictive of Mortality in Pulmonary Hypertension [J].

Mazurek, Jeremy A. ;

Horne, Benjamin D. ;

Saeed, Wajeeha ;

Sardar, Muhammad R. ;

Zolty, Ronald .

HEART LUNG AND CIRCULATION, 2017, 26 (11) :1208-1215

[9] Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension [J].

Taraseviciene-Stewart, L ;

Kasahara, Y ;

Alger, L ;

Hirth, P ;

McMahon, G ;

Waltenberger, J ;

Voelkel, NF ;

Tuder, RM .

FASEB JOURNAL, 2001, 15 (02) :427-438

[10] Galectin-3 contributes to vascular fibrosis in monocrotaline-induced pulmonary arterial hypertension ratmodel [J].

Wang, Xiaoyan ;

Wang, Yanli ;

Zhang, Jinbo ;

Guan, Xue ;

Chen, Minggang ;

Li, Yumei ;

Zhang, Li .

JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 2017, 31 (05)

← 1 →